EN
Patient-first cell therapy innovation
 
Company News
06.142022
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
  • 05.282018
    TCRCure Chongqing Research Institute awarded Chongqing postdoctoral program
    TCRCure Chongqing Research Institute was officially awarded the Chongqing Postdoctoral Program by the Chongqing Municipal Human Resources and Social Security Bureau on May 18, 2019.
12
More

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer